Formulation Development Cmc Jobs in California (NOW HIRING)

Location: South San Francisco, CA.

We are seeking an experienced and highly motivated Director, CMC Formulation Development and Manufacturing to join our multidisciplinary team based in South San Francisco. This role requires the candidate to work collaboratively with the related cross‑functional teams to support our drug discovery pipeline. The successful candidate will be responsible for but not limited to those listed below.

Reporting to: Senior Director, Head of Formulation Development & Manufacturing.

This position is based in our South San Francisco headquarters and requires the employee to be onsite four days per week, as per company policy.

• Lead the formulation efforts in facilitating drug development by managing multiple CDMOs across all stages of drug development (pre‑clinical, Phase I – III, and commercial).
• Author and review technical development reports, batch records, campaign reports, change controls, corrective and preventative actions, deviations, and investigations.
• Author and review necessary technical sections in IND/IMPD/NDA supporting global CMC regulatory submission and remain current on Health Authority guidance and expectations.
• Develop DP strategies to meet program and project development targets, ensure timely and efficient delivery of high‑quality products, and facilitate regulatory approvals.
• Represent DP/CMC and participate in cross‑functional project teams and manage multiple priorities in a fast‑paced, dynamic environment and enact quick problem solving to ensure on‑time supply of drug to support PK/PD, efficacy, DRF and pilot toxicology studies, IND‑enabling activities, and clinical trials across a portfolio of programs.
• Collaborate closely in cross‑functional teams including but not limited to Medicinal Chemistry, DMPK, Analytical Chemistry, Process Chemistry, Toxicology, Quality, Project Management, CMC Regulatory, Development Sciences, and Clinical Pharmacology to achieve project goals.
• Proactively communicate with and work closely with other functions to align DP and CMC strategies to achieve and maintain aggressive timelines to ensure goals are met.
• Lead dosage form selection, formulation development, process optimization, and scale‑up activities, ensuring robust, cost‑effective, and scalable manufacturing processes.
• Lead the evaluation, selection, and management of CDMOs to perform formulation and process development, and GMP manufacture.
• Oversee technology transfer activities at CDMOs to ensure successful manufacturing and provide technical expertise in troubleshooting and resolving issues as necessary.

• Ph.D. in Pharmaceutics, Chemistry, Chemical Engineering or related discipline with a minimum of 12 years of development experience and demonstrated ability in leading cross‑functional groups. Late phase and commercial experience are a plus.
• Demonstrated track record of success in delivering timely execution of DP and CMC activities ranging from preclinical, IND‑enabling and NDA material supplies, through GMP clinical trial supplies and commercialization.
• Demonstrated expertise in small molecule formulation development (traditional oral solid dosage and enabling formulations such as ASD and HME is a plus), scale‑up and manufacturing, and phase‑appropriate control strategy and specification development.
• Experience with analytical techniques for small molecules and oral solid dose products, with proficiency in UPLC/HPLC, dissolution, and solid‑state characterization techniques such as DSC/TGA, PLM, XRPD and laser diffraction PSD method. Track records to interprete the analytical data and application to support formulation development.
• Good understanding of physico‑chemical properties of API, PK/PD correlation and development of the phase‑appropriate formulations.
• Strong understanding of quality systems including SOPs, manufacturing record review, batch release and disposition, Good Documentation Practices, cGMP data traceability, Deviations, and Change Management.
• Demonstrated knowledge and application of current industry and compendial standards and regulatory authority guidance and expectations, including ICH, FDA, MHRA, and EMA guidelines and USP‑NF, Ph. Eur, BP, and JP compendia.
• Experience in managing global CDMOs and reviewing documentation and ensuring proper guidelines are followed.
• Exceptional problem‑solving skills and ability to quickly adapt and shift focus as needed.
• Excellent interpersonal and communication skills for internal and external collaborations.
• Ability to multi‑task in a fast‑paced dynamic environment while demonstrating a calm and positive attitude and a superior work ethic.
• Excellent interpersonal communication and decision‑making skills.
• Able to travel domestic and internationally to oversee DP development and manufacturing at CDMOs.

IDEAYA offers a competitive total rewards package that reflects our pay‑for‑performance philosophy. Employees are eligible for merit‑based salary increases, company discretionary short‑term incentive plan participation, and company discretionary stock option awards (based on board approval). Our comprehensive benefits package includes medical/dental/vision coverage (100% company paid for employees and 90% company paid for dependents), 401(k), ESPP, and wellness programs.

Expected salary range for the Director, CMC Formulation Development and Manufacturing position is $215,000 – $266,000. The final salary offered to a successful candidate will depend on various factors, including office location, candidate experience, disease area expertise, industry tenure, educational background, and interview performance.

IDEAYA is an equal opportunity employer. In accordance with applicable law, IDEAYA does not discriminate in hiring or otherwise in employment based on race, color, religion, sex, national origin, age, marital or veteran status, disability, sexual orientation, or any other legally protected status. EOE/AA/Vets.

We are committed to providing reasonable accommodations to qualified individuals with disabilities. If you need assistance or an accommodation due to a disability, please get in touch with us at hr@ideayabio.com.

The Company requires that all employees working in its facilities be fully vaccinated from COVID‑19, subject to reasonable accommodations for medical or religious reasons, and/or as otherwise required by applicable law. The Company considers an individual fully vaccinated once 14 days have passed since the receipt of either the second dose in a two‑dose COVID‑19 vaccine series or a single‑dose COVID‑19 vaccine. The vaccine must have been FDA approved, have emergency use authorization from the FDA, or, for persons fully vaccinated outside of the U.S., be listed for emergency use by the World Health Organization.